Loading market dashboard
Covalon Technologies Ltd.
CVALFHealthcareOTCCA
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Covalon Technologies Ltd. (COV:CA) Q2 2026 Earnings Call Transcript
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company's profile at www.sedarplus.ca. Brent Ashton, Covalon's Chief Executive Officer, commented, “Covalon.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2026 results on Thursday, May 21, 2026, before markets open. A conference call and webcast to discuss the results will be held on Thursday, May 21, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/485973962 To listen.
Solana (NASDAQ: HSDT - Get Free Report) and Covalon Technologies (OTCMKTS:CVALF - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, analyst recommendations, profitability and institutional ownership. Valuation and Earnings This table compares Solana and
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSX: COV; OTCQX: CVALF), an advanced medical technologies company, today announced a series of important milestones reflecting the Company's growing market development and commercial momentum, and deepening engagement across the vascular access, infection prevention, and wound care sectors. Strong Engagement at Infusion Nurses Society Annual Meeting Covalon had a strong presence at the Infusion Nurses Society (INS) Annual Meeting.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Society (INS) 2026 Annual Meeting taking place in Louisville, KY from April 11 – 14, 2026. The event will bring together leading clinicians, researchers, healthcare professionals and industry leaders all dedicated to advancing vascular access and infusion therapy practice. Attendees will have the opport.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the Company has granted an aggregate of 97,674 Deferred Share Units (“DSUs”) to four of its non-employee directors that elected to receive all or a portion of their annual directors' fees for fiscal year 2026 in DSUs as opposed to cash. The DSUs were granted under the Company's Amended and Restated Omnibus Long-Term.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its fiscal 2025 Annual General and Special Meeting of Shareholders (the "Meeting") held on March 25, 2026. Shareholders voted in favour of all items of business at the Meeting and each item of business was approved by the requisite number of votes. The approved matters included.
Covalon Technologies Ltd. (COV:CA) Shareholder/Analyst Call Transcript
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon's CEO, Brent Ashton, with a Question and Answ.
